Tango Therapeutics, Inc.
TNGX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819133
In the last 90 days, Tango Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 247 institutions reported holding it in 13F filings for Q2 2026, worth $6.60B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Tango Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +46 vs. Q2 2021
- Shares held
- 65.5M
- +65.5M vs. Q2 2021
- Total value
- $844.9M
- +$844.9M vs. Q2 2021
- New holders
- 46
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 247 | $6.60B |
| Q1 2026 | 194 | $3.78B |
| Q4 2025 | 170 | $1.53B |
| Q3 2025 | 141 | $1.18B |
| Q2 2025 | 115 | $651.7M |
| Q1 2025 | 122 | $147.0M |
| Q4 2024 | 138 | $329.2M |
| Q3 2024 | 121 | $781.2M |
| Q2 2024 | 120 | $846.0M |
| Q1 2024 | 126 | $781.2M |
| Q4 2023 | 121 | $927.1M |
| Q3 2023 | 100 | $999.9M |
| Q2 2023 | 89 | $226.8M |
| Q1 2023 | 92 | $275.9M |
| Q4 2022 | 82 | $498.4M |
| Q3 2022 | 87 | $246.8M |
| Q2 2022 | 77 | $319.1M |
| Q1 2022 | 72 | $528.2M |
| Q4 2021 | 58 | $741.0M |
| Q3 2021 | 46 | $844.9M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Tango Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $250.4M | 56.81% | +19,363,975 | New |
| Boxer Capital, LLC | 6,871,642 | $88.8M | 3.10% | +6,871,642 | New |
| FMR LLC | 6,251,913 | $80.8M | 0.01% | +6,251,913 | New |
| Casdin Capital, LLC | 5,487,910 | $71.0M | 1.77% | +5,487,910 | New |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 4,373,982 | $56.6M | 0.74% | +4,373,982 | New |
| Cormorant Asset Management, LP | 3,899,185 | $48.8M | 1.98% | +3,899,185 | New |
| Southpoint Capital Advisors LP | 3,000,000 | $38.8M | 0.83% | +3,000,000 | New |
| Ra Capital Management, L.P. | 2,250,000 | $29.1M | 0.40% | +2,250,000 | New |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $24.8M | 1.54% | +1,921,790 | New |
| Avoro Capital Advisors LLC | 1,550,000 | $20.0M | 0.32% | +1,550,000 | New |
| BlackRock Inc. | 1,393,168 | $18.0M | 0.00% | +1,393,168 | New |
| Vanguard Group Inc | 1,384,826 | $17.9M | 0.00% | +1,384,826 | New |
| EcoR1 Capital, LLC | 1,300,000 | $16.8M | 0.59% | +1,300,000 | New |
| Baker Bros. Advisors LP | 750,000 | $9.70M | 0.04% | +750,000 | New |
| Harvard Management Co Inc | 708,385 | $9.16M | 0.54% | +708,385 | New |
| Samsara BioCapital, LLC | 700,000 | $9.05M | 1.50% | +700,000 | New |
| RTW Investments, LP | 600,000 | $7.76M | 0.12% | +600,000 | New |
| Woodline Partners LP | 500,040 | $6.47M | 0.11% | +500,040 | New |
| Tang Capital Management LLC | 468,750 | $6.06M | 1.26% | +468,750 | New |
| Geode Capital Management, LLC | 428,635 | $5.54M | 0.00% | +428,635 | New |
| Alyeska Investment Group, L.P. | 424,638 | $5.49M | 0.07% | +424,638 | New |
| Citadel Advisors LLC | 408,525 | $5.28M | 0.01% | +408,525 | New |
| Farallon Capital Management, L.L.C. | 300,000 | $3.88M | 0.02% | +300,000 | New |
| Avidity Partners Management LP | 300,000 | $3.88M | 0.10% | +300,000 | New |
| State Street Corp | 198,100 | $2.56M | 0.00% | +198,100 | New |
| Northern Trust Corp | 113,150 | $1.46M | 0.00% | +113,150 | New |
| Nantahala Capital Management, LLC | 100,000 | $1.29M | 0.08% | +100,000 | New |
| Pura Vida Investments, LLC | 84,762 | $1.10M | 0.08% | +84,762 | New |
| Ensign Peak Advisors, Inc | 53,500 | $692.0K | 0.00% | +53,500 | New |
| Affinity Asset Advisors, LLC | 50,000 | $647.0K | 0.26% | +50,000 | New |
| Walleye Capital LLC | 41,415 | $535.0K | 0.02% | +41,415 | New |
| Janney Montgomery Scott LLC | 40,000 | $517.0K | 0.00% | +40,000 | New |
| Aviva Holdings Ltd. | 26,961 | $349.0K | 0.05% | +26,961 | New |
| Bank of New York Mellon Corp | 25,221 | $326.0K | 0.00% | +25,221 | New |
| Charles Schwab Investment Management Inc | 24,311 | $315.0K | 0.00% | +24,311 | New |
| Cubist Systematic Strategies, LLC | 15,792 | $204.0K | 0.00% | +15,792 | New |
| Walleye Trading LLC | 13,805 | $178.0K | 0.00% | +13,805 | New |
| Old Well Partners, LLC | 11,554 | $149.0K | 0.08% | +11,554 | New |
| Victory Capital Management Inc | 11,022 | $143.0K | 0.00% | +11,022 | New |
| Penserra Capital Management LLC | 10,344 | $133.0K | 0.00% | +10,344 | New |
| Citigroup Inc | 3,169 | $41.0K | 0.00% | +3,169 | New |
| Morgan Stanley | 1,847 | $24.0K | 0.00% | +1,847 | New |
| JPMorgan Chase & Co | 1,812 | $23.0K | 0.00% | +1,812 | New |
| Tower Research Capital LLC (TRC) | 828 | $11.0K | 0.00% | +828 | New |
| Wells Fargo & Company | 391 | $5.00K | 0.00% | +391 | New |
| Bank of America Corp | 30 | $0 | 0.00% | +30 | New |